DyAb: sequence-based antibody design and property prediction in a low-data regime

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	bioRxiv (Feb 2, 2025)
1. Verfasser:	Joshua Yao-Yu Lin
Weitere Verfasser:	Hofmann, Jennifer L, Leaver-Fay, Andrew, Wei-Ching, Liang, Vasilaki, Stefania, Lee, Edith, Pinheiro, Pedro O, Tagasovska, Natasa, Kiefer, James R, Wu, Yan, Seeger, Franziska, Bonneau, Richard, Gligorijevic, Vladimir, Watkins, Andrew, Cho, Kyunghyun, Frey, Nathan C
Veröffentlicht:	Cold Spring Harbor Laboratory Press
Schlagworte:	Protein folding Predictions Drug development Amino acid sequence Protein engineering Proteins
Online-Zugang:	Citation/Abstract Full Text - PDF Full text outside of ProQuest
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!

Beschreibung
Abstract:	Protein therapeutic design and property prediction are frequently hampered by data scarcity. Here we propose a new model, DyAb, that addresses these issues by leveraging a pair-wise representation to predict differences in protein properties, rather than absolute values. DyAb is built on top of a pre-trained protein language model and achieves a Spearman rank correlation of up to 0.85 on binding affinity prediction across molecules targeting three different antigens (EGFR, IL-6, and an internal target), given as few as 100 training data. We employ DyAb in two design contexts: as a ranking model to score combinations of known mutations, and combined with a genetic algorithm to generate new sequences. Our method consistently generates novel antibody candidates with high binding rates, including designs that improve on the binding affinity of the lead molecule by more than ten-fold. DyAb represents a powerful tool for engineering therapeutic protein properties in low data regimes common in early-stage drug development.Competing Interest StatementThe authors have declared no competing interest.
ISSN:	2692-8205
DOI:	10.1101/2025.01.28.635353
Quelle:	Biological Science Database